Size: 101-250
Headquarters: South San Francisco, California, United States, North America
Website: https://www.arsenalbio.com
Description: ArsenalBio is building a programmable cell therapy company to create highly effective and accessible immune cell therapies to impact outcomes for a much broader number of patients, initially those with cancer. Founded in 2019, ArsenalBio is focused on integrating technologies such as CRISPR-based genome engineering, scaled and high throughput target identification, synthetic biology, and machine learning to advance a new paradigm to discover and develop immune cell therapies. With its programmable and computationally driven approach, ArsenalBio aspires to evolve critical metrics of success for immune cell therapies, including enhanced and broader efficacy, increased patient safety, reduced provider costs, and expanded market access.
Linkedin:https://www.linkedin.com/company/aresnalbio
Facebook:https://www.facebook.com/ArsenalBio
Twitter:https://twitter.com/arsenalbio
TechStackLeads is a B2B go-to-market search engine. We help sales teams find prospect faster with greate accuracy.
Our search engine indexes companies, jobs, blogs, news, and funding events so you can find the right propsects faster. Enter a keyword or phrase below to see results instantly.